Double-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder | Zendy

Fatemeh Sadat Hosseini | Zendy; Fariba Amini | Zendy; Seyed Mojtaba Yassini Ardekani | Zendy; Neda Shariat | Zendy; Mohammad Nadi Sakhvidi | Zendy

Open Access

Double-Blind Randomized Clinical Trial of the Efficacy of Venlafaxine Versus Citalopram in the Treatment of the Acute Phase of Major Depressive Disorder

Author(s) -

Fatemeh Sadat Hosseini,

Fariba Amini,

Seyed Mojtaba Yassini Ardekani,

Neda Shariat,

Mohammad Nadi Sakhvidi

Publication year - 2015

Publication title -

iranian journal of psychiatry and behavioral sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.28

H-Index - 17

eISSN - 1735-9287

pISSN - 1735-8639

DOI - 10.17795/ijpbs1041

Subject(s) - citalopram , venlafaxine , nausea , major depressive disorder , depression (economics) , antidepressant , vomiting , medicine , anesthesia , randomized controlled trial , psychology , psychiatry , macroeconomics , amygdala , hippocampus , economics

The efficacy of venlafaxine and citalopram are almost the same, but compliance for the use of medication, such as nausea and vomiting, in patients using venlafaxine is much higher than the citalopram group. Therefore, this implies that citalopram could be a safer antidepressant for patients suffering from major depression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research